Aden Ka-Yin Chan Selected Research

Elements

3/2014

Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aden Ka-Yin Chan Research Topics

Disease

9	Neoplasms (Cancer) 01/2020 - 03/2014
8	Glioma (Gliomas) 01/2022 - 01/2013
5	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2013
4	Astrocytoma (Pilocytic Astrocytoma) 09/2021 - 10/2017
1	Medulloblastoma 01/2017

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2021 - 10/2017
3	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2017 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 03/2014
1	ChromatinIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 09/2018
1	ParaffinIBA 09/2018
1	NucleotidesIBA 01/2018
1	OligonucleotidesIBA 01/2018
1	KinesinsIBA 01/2017
1	ElementsIBA 03/2014
1	Carrier Proteins (Binding Protein)IBA 03/2014
1	Codon (Codons)IBA 01/2013

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2015
1	Therapeutics 09/2015